Omega Century Institute Of Oncology Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 13-12-2024
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.60 Cr
as on 13-12-2024
- Revenue 20.02%
(FY 2023)
- Profit 82.66%
(FY 2023)
- Ebitda -58.22%
(FY 2023)
- Net Worth -8.07%
(FY 2023)
- Total Assets 7.40%
(FY 2023)
About Omega Century Institute Of Oncology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹4.60 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mohan Chigurupati and Hara Chigurupati serve as directors at the Company.
- CIN/LLPIN
U85100TG2018PTC127868
- Company No.
127868
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Oct 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Omega Century Institute Of Oncology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Chigurupati  | Director | 25-Oct-2018 | Current |
| Hara Chigurupati | Director | 16-Aug-2022 | Current |
Financial Performance and Corporate Structure Insights of Omega Century Institute Of Oncology.
Omega Century Institute Of Oncology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.02% increase. The company also saw a substantial improvement in profitability, with a 82.66% increase in profit. The company's net worth dipped by a decrease of 8.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Omega Century Institute Of Oncology?
Unlock access to Omega Century Institute Of Oncology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Hyderabad Institute Of Oncology Private LimitedActive 14 years 11 monthsMohan Chigurupati is a mutual person
- Guntur Institute Of Oncology Private LimitedActive 10 years 29 days
Hara Chigurupati is a mutual person
Kakatiya Institute Of Oncology Private LimitedActive 6 years 10 monthsHara Chigurupati is a mutual person
Bhimavaram Institute Of Oncology Private LimitedActive 4 years 4 monthsMohan Chigurupati and Hara Chigurupati are mutual person
- Hare Krishna Superspeciality Hospitals Private LimitedActive 3 years 1 month
Mohan Chigurupati and Hara Chigurupati are mutual person
- Latur Institute Of Health Sciences Private LimitedActive 2 months 25 days
Mohan Chigurupati and Hara Chigurupati are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Jun 2020 | ₹4.05 Cr | Satisfied |
Others Creation Date: 09 May 2019 | ₹5.50 M | Satisfied |
How Many Employees Work at Omega Century Institute Of Oncology?
Unlock and access historical data on people associated with Omega Century Institute Of Oncology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omega Century Institute Of Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omega Century Institute Of Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
